LONDON (Reuters) - Patients with type 2 diabetes are less likely to reach target blood sugar levels on Novo Nordisk's long-lasting insulin Levemir than on shorter-acting products, researchers said on ...

As a special education teacher living with Type 1 diabetes in Crawfordsville, I’ve relied on insulin to manage my condition since my diagnosis in 2011. Despite my engagement as an #insulin4all ...

Novo Nordisk will meet with the aides for Senators Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren. In April, the lawmakers wrote to the company expressing alarm at its decision, announced in ...

A year ago today, Novo Nordisk announced significant list price reductions on its insulin medications. Unlike co-payment caps or discount cards, these were real cuts in the actual cost to patients and ...

Senators are demanding to know why Novo Nordisk discontinued Levemir, one of the nation’s three long-acting insulins. In an April 16 letter, New Hampshire Sen. Jeanne Shaheen, Georgia Sen. Raphael ...

Novo Nordisk (NVO) is reportedly set to meet with U.S. Senate aides on Tuesday to discuss why the drugmaker is discontinuing marketing its long-acting insulin Levemir in the U.S. The Danish drugmaker ...

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient groups all counted the move as a win. But several ...

Novo Nordisk maintains that patients have ample time to transition to other options. Novo Nordisk, Eli Lilly, and Sanofi control 100% of the insulin market in the U.S Get two weeks of free access to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today we have some developments about Novo Nordisk’s insulin ...

COPENHAGEN, Oct 22 (Reuters) - Denmark's Novo Nordisk , the world's biggest maker of insulin, said on Monday Japanese health authorities have approved it long-acting insulin Levemir for use in type 1 ...

Novo Nordisk announced today that the FDA has approved Levemir for a pregnancy Category B classification, indicating that Levemir,, when used in pregnant women with diabetes, did not increase the risk ...